Phase II
5 benchmark(s) tagged with this stage. ← All stages
| Name | Modalities | Validation | Score | Flags |
|---|---|---|---|---|
| ClinBench Quarterly (Insilico) | cross-modality | Clinical | 81.5 | |
| CPTAC Proteogenomic Benchmarks | cross-modality | Clinical | 80.8 | |
| HINT / TrialBench | cross-modality | Clinical | 76.5 | |
| Simcyp Validation Sets | small-molecule | Retrospective | 74.4 | license-gated-commercial |
| CT-Outcome (TrialBench v2) | cross-modality | Clinical | 73.4 |